IRIS
MACCARI, Rosanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.590
EU - Europa 4.109
AS - Asia 2.201
SA - Sud America 847
AF - Africa 54
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.810
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.531
RU - Federazione Russa 1.384
SG - Singapore 984
IE - Irlanda 759
BR - Brasile 758
SE - Svezia 687
CN - Cina 615
UA - Ucraina 337
HK - Hong Kong 300
DE - Germania 297
IT - Italia 183
FI - Finlandia 149
GB - Regno Unito 122
VN - Vietnam 82
PL - Polonia 69
IN - India 50
FR - Francia 32
AR - Argentina 27
CA - Canada 26
BD - Bangladesh 25
AT - Austria 21
MX - Messico 21
TR - Turchia 19
IQ - Iraq 17
BE - Belgio 16
EC - Ecuador 16
PK - Pakistan 16
UZ - Uzbekistan 16
MA - Marocco 15
VE - Venezuela 13
NL - Olanda 12
KE - Kenya 11
IR - Iran 10
ZA - Sudafrica 10
ID - Indonesia 9
JP - Giappone 9
CO - Colombia 8
CL - Cile 7
CZ - Repubblica Ceca 7
LT - Lituania 7
AU - Australia 6
ES - Italia 6
PY - Paraguay 6
EG - Egitto 5
KR - Corea 5
PE - Perù 5
TN - Tunisia 5
IL - Israele 4
LB - Libano 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BO - Bolivia 3
CR - Costa Rica 3
JO - Giordania 3
KZ - Kazakistan 3
LK - Sri Lanka 3
LV - Lettonia 3
NO - Norvegia 3
OM - Oman 3
PT - Portogallo 3
UY - Uruguay 3
BN - Brunei Darussalam 2
CH - Svizzera 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
HR - Croazia 2
JM - Giamaica 2
PS - Palestinian Territory 2
RS - Serbia 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CG - Congo 1
CI - Costa d'Avorio 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
KG - Kirghizistan 1
KW - Kuwait 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PH - Filippine 1
RO - Romania 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.810
Salva come PNG Salva come JPEG
Città #
Dublin 759
Moscow 724
Jacksonville 617
Chandler 600
Dallas 517
Singapore 467
Nyköping 437
Ashburn 429
Dearborn 390
Hong Kong 300
Beijing 293
Princeton 120
Medford 116
Cambridge 109
Los Angeles 107
Ann Arbor 81
Boardman 79
Munich 78
The Dalles 77
Des Moines 72
Warsaw 66
Buffalo 61
Messina 57
New York 56
São Paulo 49
Ho Chi Minh City 40
San Mateo 34
Woodbridge 33
Turku 31
Jinan 30
Wilmington 28
Tianjin 27
Lancaster 23
Belo Horizonte 21
Seattle 19
Vienna 19
Rio de Janeiro 18
Denver 17
Phoenix 17
Redondo Beach 17
Brussels 16
Haikou 15
Santa Clara 15
Brasília 13
Houston 13
Nanjing 13
Stockholm 13
Tashkent 13
Chennai 12
Salvador 12
Shenyang 12
Boston 11
Curitiba 11
Guangzhou 11
Hefei 11
Montreal 11
Orem 11
Taizhou 11
Düsseldorf 10
Francofonte 10
Hebei 10
Taiyuan 10
Washington 10
Atlanta 9
Johannesburg 9
London 9
Sorocaba 9
Tokyo 9
Ardabil 8
Baghdad 8
Brooklyn 8
Campinas 8
Fuzhou 8
Helsinki 8
Milan 8
Nairobi 8
Nanchang 8
Pune 8
San Francisco 8
Chicago 7
Columbus 7
Contagem 7
Dhaka 7
Frankfurt am Main 7
Hanoi 7
Mexico City 7
Mumbai 7
Amsterdam 6
Auburn Hills 6
Changsha 6
Charlotte 6
Fortaleza 6
Goiânia 6
Guarulhos 6
Istanbul 6
Jakarta 6
Norwalk 6
Piracicaba 6
Poplar 6
Porto Alegre 6
Totale 7.576
Salva come PNG Salva come JPEG
Nome #
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 191
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 163
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 149
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 149
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 147
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 147
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 144
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 143
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 141
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 140
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 138
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 137
2-(4-pyridyl)-Delta(2)-1,3,4-oxadiazolines from isonicotinoylhydrazones and diazomethane as potential antimycobacterial and anti-HIV agents .5. 137
(5-Arylidene-2,4-dioxothiazolidin-3-yl)acetic acids as aldose reductase inhibitors 134
3-ARYL-5-ARYLIDENE-2-THIOXO-4-IMIDAZOLIDINONE DERIVATIVES AS NEW PTP1B ALLOSTERIC INHIBITORS 134
2,4-Thiazolidinediones as in vitro ALR2 inhibitors for the treatment of diabetic complications 133
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 130
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 129
Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures 129
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 127
2,4-thiazolidinedione and 2-thioxo-4-thiazolidinone derivatives as aldose reductase inhibitors in the search for drugs to prevent long-term diabetes complications. 127
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 126
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 125
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 125
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 124
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications 121
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 120
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 119
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatase inhibitors. 118
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 117
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 116
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 115
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 114
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 112
Structure of Aldehyde Reductase in Ternary Complex with a 5-Arylidene-2,4-thiazolidinedione Aldose Reductase Inhibitor 111
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. 111
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications 111
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 110
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B 110
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents 108
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 108
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 107
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 107
Design and synthesis of dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B 107
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 106
Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions 105
(5-Arylidene-2-thioxo-4-oxothiazolidin-3-yl)acetic acids endowed with chondroprotective and matrix metalloproteinase inhibitory activities 104
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 103
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 102
Sintesi di nuovi inibitori dell’aldoso reduttasi come agenti per il trattamento delle complicazioni diabetiche. 102
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 102
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 100
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 99
New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells 99
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 98
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 97
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 96
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 95
Comparative activity of 5-arylidene-2-thioxo-4-thiazolidinone derivatives in chondrocytes and cartilage: MMP-3 inhibition and determination of GAGs release. 95
Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells 95
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 94
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 94
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 94
Non-carboxylic acid 5-arylidene-2,4-thiazolidinedione derivatives as aldose reductase inhibitors 93
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 93
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 92
Low Molecular Weight Phosphotyrosine Protein Phosphatases as Emerging Targetsfor the Design of Novel Therapeutic Agents 92
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 91
Sintesi e valutazione di derivati 2,4-tiazolidindionici non carbossilici come inibitori dell'aldoso reduttasi 91
Nuovi derivati 5-feniletossibenziliden-4-tiazolidinonici attivi come inibitori della protein tirosina fosfatasi 1B. 91
VALUTAZIONE DI COX-2 SELETTIVITÀ SU 3,3'-(1,2-ETANEDIIL)-BIS[2-(3,4-DIMETOSSIFENIL)-4-TIAZOLIDINONI] CHIRALI 90
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 90
Sintesi di 5-ariliden-2-fenilimino-4-tiazolidinoni attivi come inibitori di protein tirosina fosfatasi. 90
EVALUATION OF 4-THIAZOLIDINONE DERIVATIVES AS ALPHA-AMYLASE INHIBITORS 90
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 89
Progettazione e sintesi di 5-ariliden-4-tiazolidinoni e analoghi come inibitori di protein tirosina fosfatasi 89
Valutazione dell'attività antidegenerativa di 2-tiosso-4-tiazolidinoni su colture di condrociti umani 89
Azione insulinomimetica di acidi [4-(5-ariliden-2-arilimino-4-ossotiazolidin-3-il)metil]benzoici attivi come inibitori delle fosfatasi PTP1B e LMW-PTP 89
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 88
HALOGENATED ISONIAZID DERIVATIVES AS POSSIBLE ANTIMYCOBACTERIAL AND ANTI-HIV AGENTS .3. 88
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 87
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 87
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 87
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 86
HALOGENATED ISONIAZID DERIVATIVES .4. 1-METHYLIDENEAMINO-2- TRIFLUOROMETHYLAZIRIDINES FROM ISONICOTINOYLHYDRAZONES AND DIAZOMETHANE 86
In vitro Antimycobacterial Activity of Isoniazid-related Metalchelates 84
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 84
Sintesi e valutazione in vitro di 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori di protein tirosina fosfatasi 83
Halogenated isoniazid derivatives .6. Evaluation of anti-HSV-1 and anti-HIV-1 in vitro activities of fluorinated analogues 83
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 82
Protein-tyrosine phosphatase-1B mediates sleep fragmentation-induced insulin resistance and visceral adipose tissue inflammation in mice 82
Nuovi 5-ariliden-2,4-tiazolidindioni inibitori dell’aldoso reduttasi. 81
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 81
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 80
Nuovi inibitori competitivi non fosforilati delle fosfotirosina protein fosfatasi. 80
Tetraplex DNA specific ligand based on the fluorenone-carboxamide scaffold. 79
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives 77
Chondroprotective activity of 5-arylidene-4-thiazolidinone derivatives as new inhibitors of matrix metalloproteinase-13 77
Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI. 77
Nuovi 5-ariliden-2,4-tiazolidindioni non carbossilici inibitori dell'aldoso reduttasi 76
Totale 10.665
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.184
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.184
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021448 0 0 0 0 0 99 12 82 28 105 83 39
2021/2022700 6 100 13 22 43 5 57 24 10 33 125 262
2022/20232.254 161 236 102 217 166 235 63 101 902 10 52 9
2023/2024395 32 78 49 35 46 80 6 20 0 13 2 34
2024/20252.140 21 21 41 135 82 38 57 445 578 128 188 406
2025/20263.750 304 501 483 477 513 1.472 0 0 0 0 0 0
Totale 11.893